Items Tagged ‘I’

May 17th, 2016

idarucizumab

By

Class: Biologic Therapy Generic Name: idarucizumab Trade Name: Praxbind For which conditions is this drug approved? Praxbind® is indicated for patients specifically treated with Pradaxa® (dabigatran etexilate mesylate), an anti-clotting agent, when reversal of the anti-clotting effects of the agent is needed for emergency procedures, life-threatening instances, or uncontrolled bleeding. What is the mechanism of action?  Praxbind is a […]

View full entry

Tags: Biological Therapy, Drug Dictionary, I


April 12th, 2016

irinotecan liposome injection

By

Class: Chemotherapy Generic Name: irinotecan liposome injection Trade Name: Onivyde™ For which conditions is this drug approved? Onivyde in combination with fluorouracil and leucovorin is indicated for the treatment of patients with metastatic pancreatic cancer whose cancer has progressed after gemcitabine-based therapy. What is the mechanism of action?  Onivyde is thought to work by blocking the action of an […]

View full entry

Tags: Chemotherapy, Drug Dictionary, I


April 6th, 2016

Imlygic™

By

Class: Viral Therapy Generic Name: talimogene laherparepvec Trade Name: Imlygic™ For which conditions is this drug approved? Imlygic can be used to treat melanomas in the skin or lymph nodes that can’t be removed with surgery. What is the mechanism of action?  Imlygic is a herpes germ that has been altered to infect and kill cancer cells. These altered […]

View full entry

Tags: Biological Therapy, Drug Dictionary, I


February 11th, 2016

Ixazomib

By

Class: Biological Therapy Generic Name: Ixazomib Trade Name: Ninlaro® For which conditions is this drug approved? Ninlaro is approved for use in combination with the medicines Revlimid® (lenalidomide) and dexamethasone to treat people with multiple myeloma who have received at least one prior treatment. What is the mechanism of action? Ninlaro is a type of […]

View full entry

Tags: Biological Therapy, Drug Dictionary, I


January 19th, 2016

Imlygic®

By

Class: Biological Therapy Generic Name: Talimogene Laherparepvec Trade Name: Imlygic® For which conditions is this drug approved? Imlygic is approved to treat patients with advanced melanoma that has come back after initial surgery. What is the mechanism of action? Imlygic is a type of immunotherapy that uses a specially designed virus to destroy cancer cells. […]

View full entry

Tags: Biological Therapy, Drug Dictionary, I


January 12th, 2016

ipilimumab

By

Class: Biological Therapy Generic Name: ipilimumab Trade Name: Yervoy™ How is this drug used? Yervoy is used for the treatment of metastatic melanoma or melanoma that cannot be surgically removed, and for an additional indication of adjuvant treatment of patients with cutaneous melanoma involving nearby lymph nodes of more than 1 mm who have undergone complete resection […]

View full entry

Tags: Biological Therapy, Drug Dictionary, I


July 20th, 2015

Zydelig

By

Class: Biological Therapy Generic Name: Idelalisib Trade Name: Zydelig® For which conditions is this drug approved? Zydelig is approved to treat patients with three types of blood cancers: chronic lymphocytic leukemia that has returned (relapsed), relapsed follicular B-cell non-Hodgkin lymphoma, and relapsed small lymphocytic lymphoma. What is the mechanism of action? Zydelig is a kinase […]

View full entry

Tags: Biological Therapy, Drug Dictionary, I


July 20th, 2015

Idelalisib

By

Class: Biological Therapy Generic Name: Idelalisib Trade Name: Zydelig® For which conditions is this drug approved? Zydelig is approved to treat patients with three types of blood cancers: chronic lymphocytic leukemia that has returned (relapsed), relapsed follicular B-cell non-Hodgkin lymphoma, and relapsed small lymphocytic lymphoma. What is the mechanism of action? Zydelig is a kinase […]

View full entry

Tags: Biological Therapy, Drug Dictionary, I


May 18th, 2015

Inlyta®

By

Class: Biological Therapy Generic Name: axitinib Trade Name: Inlyta® For which conditions is this drug approved? Inlyta is approved for the treatment of advanced renal cell carcinoma (kidney cancer) when prior treatment hasn’t worked. What is the mechanism of action? Inlyta is a kinase inhibitor. These drugs work by blocking the action of enzymes called kinases, […]

View full entry

Tags: Biological Therapy, Drug Dictionary, I, Inlyta, kidney cancer, renal cell cancer


April 24th, 2015

Ibrance®

By

Class: Biological Therapy Generic Name: Palbociclib Trade Name: Ibrance® For which conditions is this drug approved? Ibrance is approved in combination with the medicine Femara® (letrozole) for the treatment of postmenopausal women with advanced breast cancer that is estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative for first therapy. It is also used […]

View full entry

Tags: advanced breast cancer, Biological Therapy, Drug Dictionary, I, Ibrance


October 21st, 2014

IMBRUVICA®

By

Generic Name:  Ibrutinib Trade Name:  IMBRUVICA® For which conditions is this drug approved? IMBRUVICA is indicated for treatment of mantle cell lymphoma (MCL) for chronic lymphocytic leukemia (CLL), both in patients who have received at least one prior therapy;  and for Waldenström’s macroglobulinemia. What is the mechanism of action? IMBRUVICA is a tyrosine kinase inhibitor. These drugs […]

View full entry

Tags: Alphabetical Sort, Biological Therapy, Drug Dictionary, I


October 21st, 2014

Ibrutinib

By

Generic Name:  Ibrutinib Trade Name:  IMBRUVICA® For which conditions is this drug approved? IMBRUVICA is indicated for treatment of mantle cell lymphoma (MCL) for chronic lymphocytic leukemia (CLL), both in patients who have received at least one prior therapy; and for Waldenström’s macroglobulinemia. What is the mechanism of action? IMBRUVICA is a tyrosine kinase inhibitor. These drugs work […]

View full entry

Tags: Alphabetical Sort, Biological Therapy, Drug Dictionary, I


April 23rd, 2014

Injectafer®

By

Class: Supportive Care Generic Name: ferric carboxymaltose (FER-ik kar-box-ee-MAWL-tose) injection Trade Name: Injectafer® For which conditions is this drug approved? Injectafer is indicated for the treatment of iron deficiency anemia in adult patients: Who have intolerance to oral iron or have had unsatisfactory response to oral iron Who have non-dialysis dependent chronic kidney disease What […]

View full entry

Tags: Alphabetical Sort, Drug Dictionary, I, Supportive


April 23rd, 2014

Injectafer®

By

Class: Supportive Care Generic Name: ferric carboxymaltose (FER-ik kar-box-ee-MAWL-tose) injection Trade Name: Injectafer® For which conditions is this drug approved? Injectafer is indicated for the treatment of iron deficiency anemia in adult patients: Who have intolerance to oral iron or have had unsatisfactory response to oral iron Who have non-dialysis dependent chronic kidney disease What […]

View full entry

Tags: Alphabetical Sort, Drug Dictionary, I, Supportive


April 17th, 2014

interstitial

By

Pertaining to or situated between parts or in the interspaces of a tissue.

View full entry

Tags: Cancer Dictionary, I